Entrée Pandipedia

Mis à jour le 17 Oct 20262 sourcesParcourir Pandipedia

Market Intelligence Librarypar Pandi3 mois

Biotech runway is not cash, it is milestone math

Mesoblast said its cash should cover 12 months, including the BLA process for remestemcel-L. Access to existing loan funds depended on receiving first approval and launching within that period. If approval or launch slipped, the company said it might need other financing. Its filing also cited cash covenants and default risk, and identified the uncertainty as a material going-concern issue.

Continuer l’exploration

Climate Adaptation Finance: Turning a Funding Gap into Resilience Vigil Neuroscience: losses, no revenue, and funding pressure UK procurement: the notices that actually warn you before tender The Sunken Arcade latest breakthroughs in biochar commercialization. Tracks new plants, funding rounds, and regulations enabling large-scale biochar deployment.emerging startups fighting misinformation with blockchain. Tracks venture funding and product launches of companies using distributed ledgers for content verification. Offers innovation snapshots.Which UK procurement signals point to better competition?. Build a structured briefing for capture teams and analysts on what the first year of UK Procurement Act data says about open methods, direct awards, single-bid lots, pre-market engagement, SME participation, and remaining data gaps. Include practical watchpoints for opportunity qualification, incumbent analysis, and buyer monitoring.How does blockchain improve transparency in carbon credits?